Amgen Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 May 24 | SellCHF 599,603 | Nancy Grygiel | Individual | 2,117 | CHF 283.23 |
Insider Trading Volume
Insider Buying: 000907582 insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 24,975 | 0.00467% |
State or Government | 256,786 | 0.048% |
Individual Insiders | 822,234 | 0.154% |
General Public | 118,810,455 | 22.2% |
Institutions | 415,263,577 | 77.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
49,035,981 | CHF 11.6b | 0.34% | 0.25% | |||
47,574,884 | CHF 11.3b | 1.32% | 0.26% | |||
12,137,491 | CHF 2.9b | 2.87% | 0.32% | |||
9,236,048 | CHF 2.2b | -8.99% | 0.14% | |||
6,320,990 | CHF 1.5b | 30.6% | 0.17% | |||
4,060,618 | CHF 961.8m | -3.63% | 0.29% | |||
3,911,181 | CHF 926.4m | 3.38% | 0.32% | |||
3,292,498 | CHF 779.8m | 0.32% | 0.6% | |||
3,252,854 | CHF 770.5m | 0% | 0.12% | |||
2,977,041 | CHF 705.1m | 7.43% | 0.19% | |||
2,955,162 | CHF 699.9m | -0.52% | 0.21% | |||
2,788,142 | CHF 660.4m | -12.9% | 0.06% | |||
2,682,244 | CHF 635.3m | 19% | 0.42% | |||
2,506,435 | CHF 593.7m | 1% | 0.21% | |||
2,413,126 | CHF 571.6m | 0.86% | 0.13% | |||
2,225,549 | CHF 527.1m | 2.08% | 0.47% | |||
2,127,468 | CHF 503.9m | 3.99% | 0.15% | |||
2,001,077 | CHF 474.0m | 26.8% | 0.4% | |||
1,932,948 | CHF 457.8m | -4.83% | 1.06% | |||
1,801,041 | CHF 426.6m | -2.88% | 0.17% | |||
1,748,598 | CHF 414.2m | 4.72% | 0.36% | |||
1,718,633 | CHF 407.1m | -10.9% | 0.33% | |||
1,636,909 | CHF 387.7m | -48.2% | 0.18% | |||
1,575,642 | CHF 373.2m | -0.02% | 2.11% | |||
1,546,100 | CHF 366.2m | 0% | 0.29% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/12/03 06:19 |
End of Day Share Price | 2023/09/05 00:00 |
Earnings | 2023/09/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Amgen Inc. is covered by 66 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
Brian Skorney | Baird |
Ishan Majumdar | Baptista Research |